investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Investment House LLC's Q3 vs. Q4 2022: 13F Holdings Reveal Shakeup in Top Stocks

Ava Hoppe | 23 April, 2023

Investment House LLC has released its 13F statements for Q3 and Q4 of 2022, indicating major changes in their top stock holdings from quarter to quarter. The fund is showing bullish-leaning positions long-term, holding on to top-performing companies and even increasing its stakes in many, despite modest overall losses in value. Here's a closer look at some of the most significant changes in holdings from Q3 to Q4 and what this tells us about the current state of the market.

First and foremost, it's worth noting that the fund shifted its focus a bit in the last quarter toward technology stocks, while decreasing its positions in consumer staples, healthcare, and industrial companies. Apple Inc (AAPL) remains the fund's most substantial holding, with a decrease of around 7.9% in the number of shares held.

There were two new additions to the top ten holdings of Investment House LLC in Q4, with NVIDIA Corporation (NVDA) and Booking Holdings Inc (BKNG) replacing payments company PayPal Holdings Inc (PYPL) and fast-food giant Yum Brands Inc (YUM). NVIDIA has rapidly established itself as a favorite among investors thanks to bullish sentiment regarding the potential of its chipmaking technology, and the fund increased its position in the company by nearly 19% in Q4.

On the other hand, there were some significant decreases in holdings for other technology stocks over this period. Amazon.com Inc (AMZN) saw a decrease of almost 24%, while PayPal saw a decrease of just over 18%. However, it's worth noting that these stocks had soared for much of the year leading up to these 13F reports, so the slight pullback could be seen as a natural correction.

There were some healthcare stocks that showed strong gains in the fund's portfolio, notably Merck & Co. Inc (MRK) and Zoetis Inc (ZTS). Merck's shares increased by 34.8%, while Zoetis fell by just over 12% in the same period. The fund's increase in Merck holdings indicates a continued appetite for established pharmaceuticals companies with significant pipelines, while the fall in Zoetis is somewhat of a surprise given the wider market's bullish performance in biotech and animal health stocks.

In terms of overall value, the Investment House LLC found itself losing slightly more than 3% between Q3 and Q4, with some of the larger losses deriving from stocks that had climbed significantly through the year, such as Corning Inc (GLW). This shift in holdings suggests the fund is feeling confident about long-term positions and profitability despite modest losses, with a focus on technology remaining the crux of its investing philosophy.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.